These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36907202)

  • 1. Immunohistochemical Analysis of the Expression of Cytokeratins in Acquired Cholesteatoma and Its Clinico-Radiological Correlation.
    Kanodia A; Kakkar A; Verma Y; Roy D; Verma H; Singh CA; Monga R; Jain D; Thakar A; Sikka K
    J Audiol Otol; 2023 Apr; 27(2):97-103. PubMed ID: 36907202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.
    Hamed MA; Nakata S; Shiogama K; Suzuki K; Sayed RH; Nishimura Y; Iwata N; Sakurai K; Badawy BS; Inada KI; Tsuge H; Tsutsumi Y
    Clin Exp Otorhinolaryngol; 2017 Sep; 10(3):213-220. PubMed ID: 28073243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine aural cholesteatoma: a histological and immunohistochemical study.
    Banco B; Grieco V; Di Giancamillo M; Greci V; Travetti O; Martino P; Mortellaro CM; Giudice C
    Vet J; 2014 Jun; 200(3):440-5. PubMed ID: 24775276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S; Zheng X; Carlsöö B
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Autophagy in Acquired Cholesteatoma.
    Li Q; Ao Y; Yu Q; Zhou S
    Otol Neurotol; 2019 Dec; 40(10):e993-e998. PubMed ID: 31663994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing Cholesteatoma Secondary to Acquired Atresia of the External Auditory Canal: Clinical Perspectives.
    Jotdar A; Dutta M; Kundu S; Mukhopadhyay S
    J Clin Diagn Res; 2017 Aug; 11(8):MD01-MD03. PubMed ID: 28969167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia.
    Nobusawa A; Sano T; Negishi A; Yokoo S; Oyama T
    Pathol Int; 2014 Jan; 64(1):20-7. PubMed ID: 24471966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of canal cholesteatoma in a patient with prenatal isotretinoin exposure.
    Van Abel KM; Nelson ME; Collar RM; Lesperance MM
    Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):1082-4. PubMed ID: 20638138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteatoma: Influence of surgical technique and EAONO/JOS stage on audiological results.
    Olmedo Martínez J; Ropero Romero F; Sánchez Gómez S
    Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(3):184-190. PubMed ID: 35577434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for sensorineural hearing loss in patients with tubotympanic otitis, cholesteatoma, and tympanic membrane retractions.
    Jesic SD; Jotic AD; Babic BB
    Otol Neurotol; 2012 Aug; 33(6):934-40. PubMed ID: 22722145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporomandibular joint (TMJ) disorders as first clinical manifestations in external auditory canal cholesteatoma. A case report.
    Salimi F; Motter D; Salimi Z
    Ann Med Surg (Lond); 2022 Feb; 74():103287. PubMed ID: 35127070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic cholesteatoma arising at the bony-cartilaginous junction of the external auditory canal: a late sequela of intact canal wall mastoidectomy.
    Cronin SJ; El-Kashlan HK; Telian SA
    Otol Neurotol; 2014 Sep; 35(8):e215-21. PubMed ID: 24979397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma].
    Si Y; Zhang ZG; Huang CY; He JF; Feng LQ; Chen YB; Chen T; Huang X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):388-93. PubMed ID: 22883581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.